<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>DERMASORB AF COMPLETE KIT- clioquinol and hydrocortisone cream with hydrating gelÂ 
			Â </strong><br>Crown Laboratories<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>DERMASORB AF COMPLETE KIT</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="L5695aa23-7c81-4309-94aa-3cda2a092936"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Iodochlorhydroxyquin (Clioquinol) is an antifungal agent and a member of a family of drugs calledÂ hydroxyquinolines. Chemically, Iodochlorhydroxyquin is 5-chloro-7-iodo-quinolin-8-ol. Its structural formula is:</p>
<p><img alt="iodochlorhydroxyquin structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b1f875e9-a95b-47ff-80cc-54a2d7a2c08c&amp;name=iodochlorhydroxyquin.jpg"></p>
<p>The topical corticosteroids constitute a class of primarily synthetic steroids used as anti-inflammatory andÂ antipruritic agents. Hydrocortisone is a member of this class. Chemically hydrocortisone is pregn-4-ene-3,20-dione, 11, 17,21-trihydroxy, (11Î²)- Its structural formula is:</p>
<p><img alt="hydrocortisone structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b1f875e9-a95b-47ff-80cc-54a2d7a2c08c&amp;name=hydrocortisone.jpg"></p>
<p></p>
<p>Each gram of Dermasorb AF contains 5mg Hydrocortisone USP and 30mg Iodochlorhydroxyquin USP in a cream base consisting of water, cetyl alcohol, stearyl alcohol, cetyl palmitate, sorbic acid, sodium lauryl sulfate, glycerin, and polysorbate-80.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="La6a0df85-1909-4893-8091-31fc89281b3d"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Iodochlorhydroxyquin is a broad-spectrum antibacterial and antifungal. Its precise mechanism of action isÂ unknown. Topical corticosteroids share anti-inflammatory, antipruritic and vasoconstrictive actions. TheÂ mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. Various laboratory methods,Â including vasoconstrictor assays, are used to compare and predict potencies and some evidence suggests aÂ recognizable correlation exists between vasoconstrictor potency and therapeutic efficacy in man.</p>
</div>
<div class="Section" data-sectionCode="43682-4">
<a name="Lafaf26e8-11c0-4e87-a7db-673301438475"></a><a name="section-3"></a><p></p>
<h1>Pharmacokinetics</h1>
<p class="First">The extent of percutaneous absorption of topical corticosteroids is determined by many factors includingÂ the vehicle, the integrity of the epidermal barrier, and the use of occlusive dressings.Â Topical corticosteroids can be absorbed from normal intact skin. <span class="product-label-link" type="condition" conceptid="4053015" conceptname="Inflammation">Inflammation</span> and/or other diseaseÂ processes in the skin increase percutaneous absorption. Occlusive dressings substantially increase theÂ percutaneous absorption of the topical corticosteroids. Thus, occlusive dressings may be a valuableÂ therapeutic adjunct for treatment of resistant dermatoses. (See <a href="#L9e7ed625-1fa2-4fd6-9cee-406602fd2ee3">DOSAGE AND ADMINISTRATION</a>).</p>
<p>Once absorbed through the skin, topical corticosteroids are handled through pharmacokinetic pathwaysÂ similar to systemically administered corticosteroids. Corticosteroids are bound to plasma proteins in varyingÂ degrees. Corticosteroids are metabolized primarily in the liver and are then excreted by the kidneys. Some ofÂ the topical corticosteroids and their metabolites are also excreted into the bile.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="L736aaa06-54cb-40d1-ac56-700d192514e3"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE:</h1>
<p class="First">Based on a review of this drug by the National Academy of Sciences-National Research Council and/or otherÂ information, FDA has classified the indications as follows:Â â€œPossiblyâ€? effective: Contact or <span class="product-label-link" type="condition" conceptid="133834" conceptname="Atopic dermatitis">atopic dermatitis</span>; impetiginized <span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">eczema</span>; nummular <span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">eczema</span>; infantile <span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">eczema</span>;<br>endogenous chronic infectious <span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">dermatitis</span>; <span class="product-label-link" type="condition" conceptid="4148876" conceptname="Stasis dermatitis">stasis dermatitis</span>; <span class="product-label-link" type="condition" conceptid="133547" conceptname="Pyoderma">pyoderma</span>; nuchal <span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">eczema</span> and chronicÂ eczematoid <span class="product-label-link" type="condition" conceptid="380731" conceptname="Otitis externa">otitis externa</span>; <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> urticata; localized or disseminated <span class="product-label-link" type="condition" conceptid="4148920" conceptname="Neurodermatitis">neurodermatitis</span>; lichen simplex chronicus;Â anogenital <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span> (vulvae, scroti, ani); <span class="product-label-link" type="condition" conceptid="4029295" conceptname="Folliculitis">folliculitis</span>; bacterial dermatoses; mycotic dermatoses such as tineaÂ (capitis, cruris, corporis, pedis); <span class="product-label-link" type="condition" conceptid="433968" conceptname="Candidiasis">moniliasis</span>; intertrigo.</p>
<p>Final classification of the less-than-effective indications requires further investigation.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="L619bfc33-3ee4-473b-9403-0161ff7e5dc6"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS:</h1>
<p class="First">Risk-benefit should be considered when the following medical problems exist:</p>
<p>â€¢ Intolerance to iodochlorhydroxyquin, hydrocortisone, chloroxine, iodine, iodine-containing preparations, orÂ related compounds</p>
<p>â€¢ Herpes simplex, <span class="product-label-link" type="condition" conceptid="140633" conceptname="Vaccinia">vaccinia</span>, <span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">eczema</span> <span class="product-label-link" type="condition" conceptid="140633" conceptname="Vaccinia">vaccinia</span>, <span class="product-label-link" type="condition" conceptid="434272" conceptname="Varicella">varicella</span>, or other <span class="product-label-link" type="condition" conceptid="440029" conceptname="Viral disease">viral infections</span> of the skin</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="L246fb257-70be-4ef1-9c3d-eea5a6908a7d"></a><a name="section-6"></a><p></p>
<h1>PRECAUTIONS:</h1>
</div>
<div class="Section" data-sectionCode="34072-9">
<a name="L8cde0761-619b-4afa-9ab6-5e411ee5bed3"></a><a name="section-7"></a><p></p>
<h1>General</h1>
<p class="First">Staining of skin and fabrics may occur. Additionally, there are rare reports of discoloration (yellowing) of hairÂ and nails. Iodochlorhydroxyquin-Hydrocortisone may prove irritating to sensitized skin in rare cases. IfÂ irritation occurs, discontinue therapy. Check with physician if no improvement within 1 to 2 weeks.</p>
<p>Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-adrenal (HPA)Â axis suppression, manifestations of Cushingâ€™s syndrome, <span class="product-label-link" type="condition" conceptid="4214376" conceptname="Hyperglycemia">hyperglycemia</span>, and glucosuria in some patients. SignsÂ and symptoms of systemic toxicity, <span class="product-label-link" type="condition" conceptid="4022093" conceptname="Electrolyte imbalance">electrolyte imbalance</span>, or adrenal suppression have not been reported withÂ Iodochlorhydroxyquin-Hydrocortisone. Nevertheless, the possibility of suppression of the HPA axis duringÂ therapy should be kept in mind, especially when the drug is used under occlusive dressings, for a prolongedÂ period, or for treating extensive cutaneous areas since significant absorption of corticosteroid may occurÂ under these conditions, particularly in children and infants.</p>
<p>Patients receiving a large dose of a potent topical corticosteroid applied to a large surface area or under anÂ occlusive dressing should be evaluated periodically for evidence of HPA axis suppression by using the urinaryÂ free cortisol and ACTH stimulation tests. If HPA axis suppression is noted, an attempt should be made toÂ withdraw the drug, to reduce the frequency of application, or to substitute a less potent corticosteroid.</p>
<p>Recovery of HPA axis function is generally prompt and complete upon discontinuation of the drug.Â Infrequently, signs and symptoms of steroid withdrawal may occur, requiring supplemental systemicÂ corticosteroids.</p>
<p>Children may absorb proportionally larger amounts of topical corticosteroids and thus be more susceptibleÂ to systemic toxicity (See <a href="#L4ff0e1bd-c0f6-49d8-88dd-57b602bba894">PRECAUTIONS â€“ Pediatric Use</a>).</p>
<p>If irritation develops, topical corticosteroids should be discontinued and appropriate therapy instituted.Â Iodochlorhydroxyquin may be absorbed through the skin and interfere with <span class="product-label-link" type="condition" conceptid="4261836" conceptname="Thyroid panel">thyroid function test</span>.Â Iodochlorhydroxyquin may cause significant elevation of protein-bound iodine (PBI) or butanol-extractableÂ iodine (BEI) and a decrease in radioactive iodine (RAI) uptake. If such tests are contemplated, wait at least oneÂ month between discontinuation of therapy and performance of these tests.</p>
<p>Prolonged use may result in overgrowth of nonsusceptible organisms requiring appropriate therapy. In the<br>presence of systemic <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span>, appropriate systemic antibiotics should be used.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="L26304c81-5015-4e2c-bbe5-6c642d32fe44"></a><a name="section-8"></a><p></p>
<h1>Information for the Patient</h1>
<p class="First">Patients using Iodochlorhydroxyquin-Hydrocortisone should receive the following information and instructions:</p>
<p>1. This medication is to be used as directed by the physician.</p>
<p>2. This medication is for external use only. Do not use in or around the eyes.Â This product is not for ophthalmic use.</p>
<p>3. Patients should be advised not to use this medication for any disorderÂ other than for which it is prescribed.</p>
<p>4. Patients should report any signs of local adverse reactions especially underÂ occlusive dressing.</p>
</div>
<div class="Section" data-sectionCode="34075-2">
<a name="L858ec7ef-1f9c-43e8-a4a3-4c0ba0b77d8c"></a><a name="section-9"></a><p></p>
<h1>Laboratory Tests</h1>
<p class="First">The following tests may be helpful in evaluating HPA axis suppression:</p>
<p>Â  Â  Â  Â Urinary free cortisol test</p>
<p>Â  Â  Â  Â ACTH stimulation test</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="L0c9f2338-83cc-41dd-8faa-5ed996405631"></a><a name="section-10"></a><p></p>
<h1>Carcinogenesis, Mutagenesis, and Impairment of Fertility</h1>
<p class="First">Long-term animal studies have not been performed to evaluate the carcinogenic potential or the effect onÂ fertility of topical corticosteroids. Studies to determine mutagenicity with prednisolone and hydrocortisoneÂ have revealed negative results.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="L7b323c6a-f7f8-428f-89b8-cf6610826404"></a><a name="section-11"></a><p></p>
<h1>Pregnancy Category C</h1>
<p class="First">Although topical steroids have not been reported to have an adverse effect on pregnancy, the safety of theirÂ use in pregnant women has not been absolutely established. Use of large amounts or for prolonged periodsÂ of time is not recommended since systemic absorption may occur. In laboratory animals, increases inÂ incidence of fetal abnormalities have been associated with exposure of gestating females to topicalÂ corticosteroids, in some cases at rather low dosage levels. The more potent corticosteroids have been shownÂ to be teratogenic after dermal application in laboratory animals. There are no adequate and well-controlledÂ studies in pregnant women on teratogenic effects from topically applied corticosteroids. TopicalÂ corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to theÂ fetus. Therefore, drugs of this class should not be used extensively on pregnant patients in large amounts orÂ for <span class="product-label-link" type="condition" conceptid="4088438" conceptname="Prolonged periods">prolonged periods</span> of time.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="Le966ddad-fddb-4bf6-801a-a3050defcdd9"></a><a name="section-12"></a><p></p>
<h1>Nursing Mothers</h1>
<p class="First">It is not known whether topical administration of this drug could result in sufficient systemic absorption toÂ produce detectable quantities in breast milk. Systemically administered corticosteroids are secreted intoÂ breast milk in quantities not likely to have a deleterious effect on the infant. Nevertheless, caution should beÂ exercised when this class of drug is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="L4ff0e1bd-c0f6-49d8-88dd-57b602bba894"></a><a name="section-13"></a><p></p>
<h1>Pediatric Use</h1>
<p class="First">Use is not recommended for infants or children up to 2 years of age.Â Iodochlorhydroxyquin may produce false-positive ferric chloride test results for <span class="product-label-link" type="condition" conceptid="432872" conceptname="Phenylketonuria">phenylketonuria</span> (PKU) ifÂ iodochlorhydroxyquin is present in the neonateâ€™s diaper or urine.</p>
<p>Special care must be exercised in using this drug in a pediatric patient. It is recommended that onlyÂ low-potency topical corticosteroids that are not fluorinated and that have a free 17-hydroxyl group be used inÂ children unless there is a very specific indication for one of the other topical corticosteroids.</p>
<p>As a general rule, pediatric therapy continuing for longer than 2 weeks and consisting of doses in excess of 2Â daily applications (with low-potency corticosteroids) should be carefully evaluated by the physician. This isÂ especially important if medication is applied to more than 5-10% of the body surface or if an occlusiveÂ dressing is used. A tight-fitting diaper or one covered with plastic pants may constitute an occlusive dressing.Â Administration of topical corticosteroids to children should be limited to the least amount compatible withÂ an effective therapeutic regimen. Chronic corticosteroid therapy may interfere with the growth andÂ development of children.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="L7b9b7fec-9547-4390-a9a3-2f12ca114bf8"></a><a name="section-14"></a><p></p>
<h1>ADVERSE REACTIONS:</h1>
<p class="First">There have been a few reports of <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span> and <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> as well as thinning of the skin with easy <span class="product-label-link" type="condition" conceptid="441737" conceptname="Contusion">bruising</span>.Â The following local adverse reactions have also been reported with topical corticosteroids and iodochlorhydroxyquinÂ especially under occlusive dressings; burning; <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span>; irritation; dryness; <span class="product-label-link" type="condition" conceptid="4029295" conceptname="Folliculitis">folliculitis</span>; <span class="product-label-link" type="condition" conceptid="443720" conceptname="Blister">blistering</span>,Â <span class="product-label-link" type="condition" conceptid="4032013" conceptname="Desquamation">peeling</span>, <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">redness</span>, <span class="product-label-link" type="condition" conceptid="4275722" conceptname="Swelling">swelling</span>; <span class="product-label-link" type="condition" conceptid="443793" conceptname="Hypertrichosis">hypertrichosis</span>; <span class="product-label-link" type="condition" conceptid="4299558" conceptname="Acneiform eruption">acneiform eruptions</span>; hypopigmentation; <span class="product-label-link" type="condition" conceptid="135032" conceptname="Dermatitis due to substances taken internally">perioral dermatitis</span>; allergicÂ <span class="product-label-link" type="condition" conceptid="134438" conceptname="Contact dermatitis">contact dermatitis</span>; maceration of the skin, <span class="product-label-link" type="condition" conceptid="442777" conceptname="Generalized infection during labor">secondary infection</span>; <span class="product-label-link" type="condition" conceptid="134118" conceptname="Atrophic condition of skin">skin atrophy</span>; <span class="product-label-link" type="condition" conceptid="137054" conceptname="Skin striae">striae</span>; <span class="product-label-link" type="condition" conceptid="4273714" conceptname="Miliaria">miliaria</span> or other signs ofÂ irritation not present before therapy.</p>
<p>Discontinue therapy if any untoward reaction occurs.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="L9e7ed625-1fa2-4fd6-9cee-406602fd2ee3"></a><a name="section-15"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION:</h1>
<p class="First">Apply a thin layer to the affected area 3 or 4 times daily.</p>
</div>
<div class="Section" data-sectionCode="44425-7">
<a name="L5340a0c0-c553-4d36-8cc1-a9410277fe0c"></a><a name="section-16"></a><p></p>
<h1>PACKAGING AND STORAGE:</h1>
<p class="First">Store at room temperature 15Â°C- 30Â°C (59Â°F - 86Â°F) in original container.</p>
<p>Protect from freezing.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="L691b988e-a96f-41b3-b6f7-8daa708cfa0b"></a><a name="section-17"></a><p></p>
<h1>HOW SUPPLIED:</h1>
<p class="First">DERMASORBâ„¢AF (Hydrocortisone USP, 0.5%, Iodochlorhydroxyquin USP, 3%) Cream isÂ supplied in:<br>1 ounce tube NDC 0316-1025-01</p>
<p>Rx Only</p>
<p>PRINTED IN USA</p>
<p>P6179.01</p>
<p>Manufactured and Distributed by: Crown Laboratories, Inc., Johnson City, TN, 37604</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="Lb1c6e0f9-1987-4b8b-a6b1-7f21d940892a"></a><a name="section-18"></a><p></p>
<h1>Dermasorb AF Complete Kit</h1>
<p class="First">p618001<img alt="Dermasorb AF Trade Carton" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b1f875e9-a95b-47ff-80cc-54a2d7a2c08c&amp;name=p618001.jpg"></p>
<p></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>DERMASORB AF COMPLETE KITÂ 		
					</strong><br><span class="contentTableReg">clioquinol and hydrocortisone cream with hydrating gel kit</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0316-1025</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0316-1025-01</td>
<td class="formItem">1  in 1 KIT</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Quantity of Parts</td></tr>
<tr>
<th scope="col" width="5" class="formTitle">PartÂ #</th>
<th scope="col" class="formTitle">Package Quantity</th>
<th scope="col" class="formTitle">Total Product Quantity</th>
</tr>
<tr class="formTableRowAlt">
<td width="5" class="formItem"><strong>Part 1</strong></td>
<td class="formItem">1 TUBE </td>
<td class="formItem">28.4Â g</td>
</tr>
<tr class="formTableRow">
<td width="5" class="formItem"><strong>Part 2</strong></td>
<td class="formItem">1 TUBE </td>
<td class="formItem">114Â g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellspacing="0" cellpadding="5">
<tr><td class="contentTableTitle">Part 1 of 2</td></tr>
<tr><td class="contentTableTitle">
<strong>DERMASORB AFÂ 		
					</strong><br><span class="contentTableReg">clioquinol and hydrocortisone cream cream</span>
</td></tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0316-0203</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>HYDROCORTISONE</strong> (HYDROCORTISONE) </td>
<td class="formItem">HYDROCORTISONE</td>
<td class="formItem">5Â mg Â inÂ 1Â g</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>CLIOQUINOL</strong> (CLIOQUINOL) </td>
<td class="formItem">CLIOQUINOL</td>
<td class="formItem">30Â mg Â inÂ 1Â g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>CETYL ALCOHOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>GLYCERIN</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>STEARYL ALCOHOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>POLYSORBATE 80</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM LAURYL SULFATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CETYL PALMITATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SORBIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0316-0203-01</td>
<td class="formItem">1  in 1 KIT</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">28.4 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">11/14/2013</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellspacing="0" cellpadding="5">
<tr><td class="contentTableTitle">Part 2 of 2</td></tr>
<tr><td class="contentTableTitle">
<strong>DERMASORB HYDRATING SERUMÂ 		
					</strong><br><span class="contentTableReg">lotions, oils, powders, and creams </span>
</td></tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt"></tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Other Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Kind</th>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Quantity</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">INGR</td>
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem">INGR</td>
<td class="formItem"><strong>UREA</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">INGR</td>
<td class="formItem"><strong>PROPYLENE GLYCOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem">INGR</td>
<td class="formItem"><strong>CYCLOMETHICONE 5</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">INGR</td>
<td class="formItem"><strong>CYCLOMETHICONE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem">INGR</td>
<td class="formItem"><strong>PEG/PPG-18/18 DIMETHICONE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">INGR</td>
<td class="formItem"><strong>GLUCONOLACTONE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem">INGR</td>
<td class="formItem"><strong>AMMONIUM GLYCOLATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">INGR</td>
<td class="formItem"><strong>GLYCOLIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem">INGR</td>
<td class="formItem"><strong>DIMETHICONOL (40 CST)</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">INGR</td>
<td class="formItem"><strong>ARGININE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem">INGR</td>
<td class="formItem"><strong>CHLORPHENESIN</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">INGR</td>
<td class="formItem"><strong>PHENOXYETHANOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem">INGR</td>
<td class="formItem"><strong>CAPRYLYL GLYCOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">INGR</td>
<td class="formItem"><strong><span class="product-label-link" type="condition" conceptid="4184927" conceptname="Ammonia">AMMONIA</span></strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">1  in 1 KIT</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">114 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Cosmetic</td>
<td class="formItem"></td>
<td class="formItem">11/14/2013</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">11/14/2013</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Crown Laboratories
							(079035945)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant -Â </span>Crown Laboratories (079035945)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Crown Laboratories</td>
<td class="formItem"></td>
<td class="formItem">079035945</td>
<td class="formItem">manufacture(0316-1025)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 11/2013<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>87879f7f-edc8-42e7-8ca8-feebc31bcc29</div>
<div>Set id: b1f875e9-a95b-47ff-80cc-54a2d7a2c08c</div>
<div>Version: 2</div>
<div>Effective Time: 20131112</div>
</div>
</div>Â <div class="DistributorName">Crown Laboratories</div></p>
</body></html>
